The 68 Ga-DOTATATE PET-CT is an important imaging modality for detection of culprit
lesion of tumor induced osteomalacia (TIO) in clinically symptomatic patient of …

68Ga-DOTATATE PET/CT is an important imaging modality for detection of culprit lesions of
tumor-induced osteomalacia in clinically symptomatic patients with hypophosphatemia …

Objective To assess and compare the performance of fluorine‐18‐labeled
fluorodeoxyglucose positron emission tomography (18F‐FDG‐PET/CT) and gallium‐68 …

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by tumors
secreting fibroblast growth factor 23 (FGF23) that promotes urinary phosphorus excretion …

Tumor-induced osteomalacia (TIO) is an uncommon paraneoplastic syndrome presenting
with sustained hypophosphatemia. Treatment of choice is removal of the tumor causing the …

Objective Tumor-induced osteomalacia (TIO) is caused by typically small tumors that secrete
fibroblast growth factor 23 (FGF23). As tumor resection is the only effective treatment for TIO …

Objectives Tumor-induced osteomalacia (TIO) is generally caused by small benign
mesenchymal tumors producing fibroblast growth factor-23 (FGF-23). The only curative …

Purpose Oncogenic osteomalacia is an endocrine disorder induced by small benign
tumours (TIO) producing excessive fibroblast growth factor-23 (FGF23). The only way of …

Objective To evaluate the effect of 68 Ga-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-
tetraacetic acid-D-Phe1-Tyr3-Thr8-octreotide (DOTATATE) PET/CT imaging combined with …

Context: Tumor-induced osteomalacia (TIO) is a rarely diagnosed disorder presenting with
bone pain, fractures, muscle weakness, and moderate-to-severe hypophosphatemia …